Drag a card by its title · ⚙ to size, swap or remove

The company

Abeona Therapeutics Inc.

ABEO · Nasdaq

Health CareBiotechnologyNot moving yetSynthetic Biology / TechBio

ABEO stood above a rising 150-day average in 17 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 21.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 6
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $6.9M
Officials’ trades on record: 0
Institutions holding: 125 (+21)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months37

Buyers · sellers0 · 9

Who	Did	Shares	Traded
Madhav VasanthavadaChief Commercial Officer	sold	4,902at $5.16	29 Sep 2026filed 29 Sep 2026
Brendan M. O'MalleySVP, Chief Legal Officer	sold	6,727at $5.16	29 Sep 2026filed 29 Sep 2026
Joseph Walter VazzanoChief Financial Officer	sold	9,191at $5.16	29 Sep 2026filed 29 Sep 2026
Vishwas SeshadriChief Executive Officer	sold	19,608at $5.16	29 Sep 2026filed 29 Sep 2026
Mark AlvinoDirector	sold	15,000at $5.86	1 Sep 2026filed 1 Sep 2026
Joseph Walter VazzanoChief Financial Officer	sold	1,478at $6.53	21 Jul 2026filed 22 Jul 2026
Madhav VasanthavadaChief Commercial Officer	sold	12,606at $6.96	9 Jul 2026filed 9 Jul 2026
Brendan M. O'MalleySVP, Chief Legal Officer	sold	12,050at $6.96	9 Jul 2026filed 9 Jul 2026
Vishwas SeshadriChief Executive Officer	sold	67,971at $6.96	9 Jul 2026filed 9 Jul 2026
Joseph Walter VazzanoChief Financial Officer	sold	24,880at $6.96	9 Jul 2026filed 9 Jul 2026
Leila AllandDirector	sold	11,000at $5.92	30 Jun 2026filed 2 Jul 2026
Christine Berni SilversteinDirector	sold	18,160at $5.71	15 Jun 2026filed 15 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders125+21 on the quarter

New · exited35 · 13

Reported value$243.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Nantahala Capital Management, LLCadded · filed 14 Aug 2026	5,136,490$31.7M	+123,438+2.5%
BlackRock, Inc.added · filed 7 Aug 2026	3,352,474$20.7M	+156,944+4.9%
Cable Car Capital, LPunchanged · filed 14 Aug 2026	3,007,329$18.6M	00.0%
AIGH Capital Management LLCreduced · filed 7 Aug 2026	2,987,000$18.5M	-113,000−3.6%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,211,433$13.7M	+46,582+2.2%
OneDigital Investment Advisors LLCnew · filed 7 Aug 2026	1,653,024$10.2M	+1,653,024
AWM Investment Company, Inc.added · filed 14 Aug 2026	1,486,130$9.2M	+683,000+85.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	1,261,090$7.8M	+51,293+4.2%
KENNEDY CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026	1,240,071$7.7M	-23,440−1.9%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026	1,224,806$7.6M	+94,187+8.3%